Johnson & Johnson vs Regeneron Pharmaceuticals Inc
JNJ vs REGN — side-by-side comparison from reported financials. JNJ leads 5, REGN leads 5 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Regeneron Pharmaceuticals Inc
REGN · Healthcare
$745.55+0.81%Mixed
| Metric | JNJ | REGN |
|---|---|---|
| Price | $261.79 | $745.55 |
| Market cap | $631B | $76.8B |
| Revenue (TTM) | $97.9B | $15.5B |
| Revenue growth | +5.6% | +5.6% |
| Net margin | 21.5% | 27.9% |
| Free cash flow | $22.2B | $3.76B |
| Net cash (debt) | ($27.8B) | $6.62B |
| 1-year price return | +37.0% | +30.8% |
| P/E | 29.9 | 17.8 |
| P/E vs own history (cheap-side %) | 16% | 46% |
| Dividend yield | 2.00% | 0.49% |
| Return on equity | 26% | 14% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 15,410 |
Full résumé-style profiles: JNJ CV · REGN CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.